Related Experiment Video

Updated: Jun 3, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Well-being of obese individuals: therapeutic perspectives

Jean-Philippe Chaput1, Angelo Tremblay

  • 1Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen, Frederiksberg C, Denmark. jepc@life.ku.dk

Future Medicinal Chemistry
|March 25, 2011
PubMed

Insights

Obesity pharmacologic treatments historically prioritized efficacy over safety, leading to drug withdrawals. Future obesity drug development must integrate central nervous system (CNS) and cardiovascular safety early to prevent adverse events and ensure balanced weight management.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Cardiovascular Medicine

Background:

  • Past pharmacologic treatments for obesity overemphasized efficacy, neglecting safety concerns.
  • This focus resulted in market withdrawals due to serious adverse events, highlighting a critical gap in drug development.
  • Weight loss can paradoxically exacerbate depression and psychobiological vulnerability, potentially leading to weight regain.

Purpose of the Study:

  • To analyze the historical shortcomings in obesity pharmacologic treatment development.
  • To emphasize the necessity of integrating central nervous system (CNS) and cardiovascular safety assessments early in the development of new obesity drugs.
  • To advocate for a balanced approach in body-weight management that considers both efficacy and potential risks.

Main Methods:

  • Historical analysis of pharmacologic obesity treatments.
  • Review of adverse event data and drug withdrawal reasons.
  • Exploration of the psychobiological effects of weight loss.

Main Results:

  • A historical trend of prioritizing efficacy over safety in obesity drug development.
  • Identification of CNS and cardiovascular safety as critical factors often overlooked in early development stages.
  • Recognition of weight loss-induced depression and psychobiological vulnerability as significant challenges.

Conclusions:

  • Future obesity drug development must prioritize comprehensive safety evaluations, including CNS and cardiovascular effects, from the outset.
  • A balanced approach is needed to optimize psychobiological well-being during weight management.
  • Avoiding past mistakes requires a paradigm shift towards integrated safety and efficacy assessment in obesity pharmacotherapy.

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...